Sum­i­to­vant sub­sidiaries En­zy­vant and Al­ta­vant merge in­to com­bined com­pa­ny

Two Sum­i­to­vant Bio­phar­ma en­ti­ties are merg­ing un­der one name, ef­fec­tive im­me­di­ate­ly.

En­zy­vant Ther­a­peu­tics and Al­ta­vant Sci­ences an­nounced they have merged to form a sin­gu­lar en­ti­ty …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.